First Reported Case of Endoscopic Ultrasound-Guided Core Biopsy Yielding Diagnosis of Primary Adrenal Leiomyosarcoma.

In an open-label phase 1b and randomized phase 2 study, olaratumab plus doxorubicin achieved a highly significant improvement of 11.8 months in median overall survival thus prompting our use of this human antiplatelet-derived growth factor receptor monoclonal antibody in our patient's care [ 8 ].

also in 132,142 other papers